Agus M S, Katz L E, Satin-Smith M, Meadows A T, Hintz R L, Cohen P
Department of Pediatrics, Children's Hospital of Boston, Harvard University School of Medicine, Massachusetts, USA.
J Pediatr. 1995 Sep;127(3):403-7. doi: 10.1016/s0022-3476(95)70071-4.
Hypoglycemia occurred in a 2-year-old girl with neuroblastoma. Initially, growth hormone secretion was suppressed, and she had low levels of insulin-like growth factor (IGF)-I and IGF binding protein-3, but elevated levels of large molecular weight IGF-II. We postulated that the pathogenesis of her hypoglycemia involved production of IGF-II by her neuroblastoma, leading to GH suppression and an abnormally elevated ratio of IGF to IGF binding protein. She was successfully treated with growth hormone; treatment was associated with normalization of the growth hormone-dependent growth factor levels and with euglycemia.